CME

CME


The Latest Clinical Considerations for Non-Small Cell Lung Cancer: A Global Approach

March 30, 2021

Host: Federico Cappuzzo

Guest: Professor Solange Peters

Guest: Professor Yi-Long Wu

Are dMMR and MSI-H both markers that will soon replace or work in conjunction with PD-L1 when determining immunotherapy for patients with metastatic NSCLC? Accura